Humira (Hu-MARE-ah, adalimumab), a new biologic therapy for rheumatoid arthritis

Abbott is now introducing Humira (Hu-MARE-ah, adalimumab), a new biologic therapy for rheumatoid arthritis.

It's a tumor necrosis factor (TNF) blocking agent...similar to Remicade (infliximab) and Enbrel (etanercept).

Humira is for moderate to severe RA that's not controlled by methotrexate or other disease-modifying antirheumatic drugs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote